Javier A. Menéndez
Javier A. Menéndez
Catalan Institute of Oncology (ICO)-Girona Biomedical Research Institute (IDIBGi)
Verified email at idibgi.org
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
64332016
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
JA Menendez, R Lupu
Nature Reviews Cancer 7 (10), 763-777, 2007
20412007
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008
J López-Miranda, F Pérez-Jiménez, E Ros, R De Caterina, L Badimón, ...
Nutrition, metabolism and cardiovascular diseases 20 (4), 284-294, 2010
5502010
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
JA Menendez, L Vellon, I Mehmi, BP Oza, S Ropero, R Colomer, R Lupu
Proceedings of the National Academy of Sciences 101 (29), 10715-10720, 2004
3302004
Metformin: multi-faceted protection against cancer
S Del Barco, A Vazquez-Martin, S Cufí, C Oliveras-Ferraros, ...
Oncotarget 2 (12), 896, 2011
2982011
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
A Vazquez-Martin, C Oliveras-Ferraros, JA Menendez
Cell cycle 8 (1), 88-96, 2009
2842009
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of …
JA Menendez, L Vellon, R Colomer, R Lupu
Annals of oncology 16 (3), 359-371, 2005
2632005
Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab
A Vazquez-Martin, C Oliveras-Ferraros, JA Menendez
PloS one 4 (7), e6251, 2009
2432009
Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena
B Martin-Castillo, A Vazquez-Martin, C Oliveras-Ferraros, JA Menendez
Cell cycle 9 (6), 1057-1064, 2010
2372010
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis
S Cufi, A Vazquez-Martin, C Oliveras-Ferraros, B Martin-Castillo, J Joven, ...
Cell cycle 9 (22), 4461-4468, 2010
2242010
Autophagy in stem cells
JL Guan, AK Simon, M Prescott, JA Menendez, F Liu, F Wang, C Wang, ...
Autophagy 9 (6), 830-849, 2013
2152013
Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
A Vazquez-Martin, C Oliveras-Ferraros, S Cufí, S Del Barco, ...
Cell cycle 9 (18), 3831-3838, 2010
2042010
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
A Vazquez-Martin, C Oliveras-Ferraros, S Del Barco, B Martin-Castillo, ...
Breast cancer research and treatment 126 (2), 355-364, 2011
1902011
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A Vazquez‐Martin, R Colomer, J Brunet, R Lupu, JA Menendez
Cell proliferation 41 (1), 59-85, 2008
1892008
Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
R Lupu, JA Menendez
Current pharmaceutical biotechnology 7 (6), 483-494, 2006
1842006
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
JA Menendez, A Vazquez-Martin, R Colomer, J Brunet, ...
BMC cancer 7 (1), 80, 2007
1782007
Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer
JA Menendez, A Vazquez-Martin, FJ Ortega, JM Fernandez-Real
Clinical chemistry 55 (3), 425-438, 2009
1722009
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
JA Menendez, M del Mar Barbacid, S Montero, E Sevilla, E Escrich, ...
European journal of cancer 37 (3), 402-413, 2001
1652001
Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated …
JA Menendez, L Vellon, R Lupu
Annals of oncology 16 (8), 1253-1267, 2005
1632005
A novel CYR61-triggered ‘CYR61-α v β 3 integrin loop’regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway
JA Menendez, L Vellon, I Mehmi, PK Teng, DW Griggs, R Lupu
Oncogene 24 (5), 761-779, 2005
1582005
The system can't perform the operation now. Try again later.
Articles 1–20